Bottom line
Is TNRAX a good fund? The bottom line
TNRAX is the Class A share class of 1290 Avantis U.S. Large Cap Growth Fund, an actively managed large growth mutual fund from American Century.
Its expense ratio is 0.9% — about $90 a year on every $10,000 invested, more expensive than 54% of large growth funds we track.
It returned +10.3% over one year (as of Dec 31, 2025, per its prospectus).
With $209 million in net assets and 235 holdings, its largest position is NVIDIA Corp. (11.2%) and the top 10 make up 53.9% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
The closest lower-cost alternative we found is VUG (0.03%, 84% top-holdings overlap).
What stands out
- Broadly diversified (235 holdings)
What to watch
- Concentrated: top 10 holdings are 53.9% of assets
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What TNRAX invests in
Seeks to provide long-term growth of capital.
Under normal market conditions, the Fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in securities of large capitalization U.S. companies (or other financial instruments that derive their value from the securities of such companies). For the Fund, large capitalization companies are those companies with market capitalizations at least as large as the smallest company in the Russell 1000 Index (a widely used benchmark of the largest domestic stocks) or companies included in the Russell 1000 Growth Index (a widely used benchmark of the largest domestic growth stocks). Though market capitalizations will change from time to time, as of December 31, 2025, the market capitalizations of the companies in the Russell 1000 Index ranged from approximately $1.3 billion to $4.6 trillion, and the market capitalizations of the companies in the Russell 1000…
From the fund's prospectus (filed Feb 24, 2026).
TNRAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| TNRAX | +10.3% | — | — |
| Large Growth median | +15.2% | +11.0% | +14.2% |
Source: Fund prospectus, as of Dec 31, 2025
What TNRAX costs
On a $10,000 investment, TNRAX's 0.9% expense ratio costs about $90 a year. The prospectus estimates $1,739 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.
TNRAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | NVIDIA Corp. | 11.23% |
| 2 | Apple, Inc. | 11.00% |
| 3 | Microsoft Corp. | 8.37% |
| 4 | Broadcom, Inc. | 4.41% |
| 5 | Meta Platforms, Inc. | 4.26% |
| 6 | Amazon.com, Inc. | 4.08% |
| 7 | Alphabet, Inc. | 3.43% |
| 8 | Alphabet, Inc. | 2.78% |
| 9 | Eli Lilly & Co. | 2.28% |
| 10 | Visa, Inc. | 2.05% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 53.9% of the fund. See all top 25 holdings and asset mix →
Alternatives to TNRAX
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| Vanguard | VUG Vanguard Growth Index Fund | 0.03% | 84% | Compare |
| Schwab | SWLGX Schwab U.S. Large-Cap Growth Index Fund | 0.035% | 85% | Compare |
| Fidelity | FSPGX Fidelity Large Cap Growth Index Fund | 0.035% | 71% | Compare |
| SPDR (State Street) | SPYG State Street(R) SPDR(R) Portfolio S&P… | 0.04% | 75% | Compare |
| iShares | IVW iShares S&P 500 Growth ETF | 0.18% | 75% | Compare |
| J.P. Morgan | JGRO JPMorgan Active Growth ETF | 0.44% | 53% | Compare |